ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Francesco Onorati
Antonio Esposito
Attilio Renzulli
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Onorati, F.
Right arrow Articles by Renzulli, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Onorati, F.
Right arrow Articles by Renzulli, A.
Related Collections
Right arrow Myocardial protection

Ann Thorac Surg 2007;83:1016-1023
© 2007 The Society of Thoracic Surgeons


Original Articles: Cardiovascular

Troponin I and Lactate From Coronary Sinus Predict Cardiac Complications After Myocardial Revascularization

Francesco Onorati, MDa,*, Lucia Cristodoro, MDa, Santo Caroleo, MDb, Antonio Esposito, MDa, Bruno Amantea, MDb, Ermenegildo Santangelo, MDb, Attilio Renzulli, MD, PhDa

a Cardiac Surgery Unit, Magna Graecia University, Catanzaro, Italy
b Anesthesiology and Critical Care Unit, Magna Graecia University, Catanzaro, Italy

Accepted for publication October 23, 2006.

* Address correspondence to Dr Onorati, Viale dei Pini, 28, Napoli 80131, Italy (Email: frankono{at}libero.it).

Background: Postoperative troponin I and lactate elevation are related to cardiac complications after myocardial revascularization. We sought to evaluate earlier predictive value for acute myocardial infarction (AMI) and myocardial damage of troponin I and lactate after myocardial revascularization.

Methods: In all, 183 consecutive isolated myocardial revascularizations were prospectively enrolled in the study. Troponin I and lactate were sampled preoperatively and intraoperatively from the coronary sinus, and at 12, 24, 48, and 72 hours. Hospital outcome was recorded. Receiver operating curves for coronary sinus troponin I and lactate were constructed to differentiate patients with or without AMI and myocardial damage.

Results: Acute myocardial infarction developed in 6 patients (3.2%), with higher troponin I and lactate at all time points (p < 0.05), longer intubation time (p = 0.003), intensive care unit stay (p = 0.001), hospital stay (p = 0.001), higher atrial fibrillation (p = 0.001), and worse ventricular function (p = 0.001). Myocardial damage developed in 6 patients (3.2%), showing higher troponin I at all time points (p < 0.001), higher intraoperative lactate (p = 0.04), longer intubation time (p = 0.005), and intensive care unit stay (p = 0.03). Receiver operating characteristic curves demonstrated coronary sinus troponin I greater than 0.94 µg/L (area under the curve [AUC] 0.820 ± 0.075; sensitivity 90.0%, specificity 68.9%) as a better discriminator between patients with or without AMI than lactate level greater than 2.85 mmol/L (AUC 0.686 ± 0.090; sensitivity 80.0%; specificity 72.9%); troponin I greater than 0.65 µg/L was a better discriminator between patients with or without myocardial damage (AUC 0.834 ± 0.061; sensitivity 93.8%, specificity 71.5%), than lactate greater than 2.05mmol/L (AUC 0.627 ± 0.067; sensitivity 87.5%; specificity 70.7%).

Conclusions: Coronary sinus troponin I and lactate are predictive for cardiac complications after myocardial revascularization. Intraoperative biochemical assays should be routinely performed to establish preventative strategies to reduce further myocardial damage.




This article has been cited by other articles:


Home page
J. Thorac. Cardiovasc. Surg.Home page
F. Onorati, A. S. Rubino, D. Marturano, E. Pasceri, G. Santarpino, S. Zinzi, G. Mascaro, and A. Renzulli
Midterm clinical and echocardiographic results and predictors of mitral regurgitation recurrence following restrictive annuloplasty for ischemic cardiomyopathy
J. Thorac. Cardiovasc. Surg., September 1, 2009; 138(3): 654 - 662.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
G. Santarpino, F. Onorati, A. S. Rubino, K. Abdalla, S. Caroleo, E. Santangelo, and A. Renzulli
Preoperative intraaortic balloon pumping improves outcomes for high-risk patients in routine coronary artery bypass graft surgery.
Ann. Thorac. Surg., February 1, 2009; 87(2): 481 - 488.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
V. A. Mannacio, D. Iorio, V. De Amicis, F. Di Lello, and F. Musumeci
Effect of rosuvastatin pretreatment on myocardial damage after coronary surgery: a randomized trial.
J. Thorac. Cardiovasc. Surg., December 1, 2008; 136(6): 1541 - 1548.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2007 by The Society of Thoracic Surgeons.